Skip to main navigation Skip to search Skip to main content

Correction: Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression (Cell Death & Disease, (2022), 13, 4, (388), 10.1038/s41419-022-04745-5)

  • Junhui Yu
  • , Kui Yang
  • , Jianbao Zheng
  • , Pengwei Zhao
  • , Jie Xia
  • , Xuejun Sun
  • , Wei Zhao
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • Chinese Academy of Medical Sciences

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The original version of this article unfortunately contained a mistake in Figure 3E. The correct figure can be found below. The authors apologise for any inconvenience caused and have confirmed that our statistical results are basically unaffected. The original article has been corrected.

Original languageEnglish
Article number101
JournalCell Death and Disease
Volume14
Issue number2
DOIs
StatePublished - Feb 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Correction: Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression (Cell Death & Disease, (2022), 13, 4, (388), 10.1038/s41419-022-04745-5)'. Together they form a unique fingerprint.

Cite this